Trending...
- Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
- SlotCycle Joins Association of Gaming Equipment Manufacturers (AGEM) to Advance Sustainable Gaming Solutions
- Southbox Entertainment, FinTech Pioneer & Entrepreneur Jon Gosier Join Psychological Thriller The Dutchman as Financing Partner
CHICAGO, Aug. 1, 2024 ~ The Association for Diagnostics & Laboratory Medicine (ADLM) welcomed a record-breaking number of laboratory experts to their annual meeting, ADLM 2024, from July 28 to August 1. Formerly known as the AACC Annual Scientific Meeting & Clinical Lab Expo, this year's event showcased groundbreaking advancements in diagnostic research and technology, highlighting the crucial role that laboratory medicine plays in patient care.
According to ADLM, as of Thursday, August 1, over 18,000 laboratory medicine professionals had registered for the meeting. This marks a significant increase of 6% in attendance since the last time the ADLM Annual Meeting was held in Chicago in 2022. With one more day left in the meeting, even more attendees are expected to join.
One of the highlights of the event was a special session featuring representatives from ADLM, the American Medical Association, and the Children's Hospital Association. They discussed how the FDA's final rule placing laboratory developed tests under FDA oversight will have a negative impact on patient care. The session also included a caregiver and patient advocate who shared their perspective on why these tests are essential for timely diagnoses and treatment.
More on eTravel Wire
Attendees were also treated to five plenary talks led by pioneers in life sciences. In the opening plenary, Dr. Patrick Bossuyt received the prestigious Wallace H. Coulter Lectureship award and spoke about his experiences leading efforts to improve diagnostic tests. He made a compelling case for why strong clinical trials of laboratory tests are necessary.
On Monday, Dr. Kojo S.J. Elenitoba-Johnson from Memorial Sloan Kettering Cancer Center discussed how proteomic data can help healthcare professionals better understand lymphomas and develop precision oncology therapies.
Tuesday's plenary speaker was Dr. Ron H.N. van Schaik from Erasmus MC - University Medical Center Rotterdam who talked about implementing pharmacogenetics as a diagnostic tool in routine healthcare. He shared both the successes and challenges of this approach.
On Wednesday, Dr. Sharon Hillier from the University of Pittsburgh explored the development of new products for HIV prevention, including those that can be used on demand and minimize exposure to antiretroviral drugs.
The closing keynote speaker, Dr. Diana Greene Foster from the University of California, San Francisco, discussed the mental health, physical health, and socioeconomic consequences faced by individuals who are unable to get an abortion.
More on eTravel Wire
As part of ADLM's Disruptive Technology Award competition, biotech innovators presented novel technologies that could improve accurate diagnoses for more patients. The winner was Mercy BioAnalytics with their liquid biopsy platform that detects ovarian cancer in its earliest stages by measuring tumor-derived extracellular vesicles.
The ADLM 2024 Clinical Lab Expo featured nearly 900 exhibitors and covered an impressive 271,003 net square feet. This marks a 5% increase in exhibit space since the last time the meeting was held in Chicago. The expo showcased cutting-edge tests from all laboratory medicine disciplines, including artificial intelligence, molecular diagnostics, automation, point-of-care testing, mass spectrometry, mobile health, and more.
ADLM CEO Mark J. Golden expressed his excitement about the increased attendance at ADLM 2024 after the challenges faced during the COVID-19 pandemic. He also acknowledged that this has been a challenging year for laboratory medicine professionals with the FDA's final rule on laboratory developed tests. The meeting provided a crucial opportunity for attendees to learn more about what this rule means for their labs and patient care. Golden hopes that attendees will return home inspired and eager to implement what they've learned at this year's meeting in their work. He also looks forward to seeing what next year's meeting in Chicago from July 27-31 will bring.
In conclusion, ADLM 2024 was a resounding success with record-breaking attendance and groundbreaking advancements in diagnostic research and technology. The meeting provided a vital platform for laboratory medicine professionals to learn, network, and stay updated on the latest developments in their field.
According to ADLM, as of Thursday, August 1, over 18,000 laboratory medicine professionals had registered for the meeting. This marks a significant increase of 6% in attendance since the last time the ADLM Annual Meeting was held in Chicago in 2022. With one more day left in the meeting, even more attendees are expected to join.
One of the highlights of the event was a special session featuring representatives from ADLM, the American Medical Association, and the Children's Hospital Association. They discussed how the FDA's final rule placing laboratory developed tests under FDA oversight will have a negative impact on patient care. The session also included a caregiver and patient advocate who shared their perspective on why these tests are essential for timely diagnoses and treatment.
More on eTravel Wire
- $1B Target by 2027 Amid eSIM, Global Roaming Expansion; $57.6M Q1 Revenue and Market Uplisting, Advancing Toward IQSTEL, Inc. (Stock Symbol: IQST)
- LIB TH-50/TH-80 Benchtop Environmental Chamber Drives Global Demand
- Marc Soucy's Newest Music Series Approaches Its One Year Mark
- Fairmint Releases Whitepaper for Open Captable Protocol (OCP) to Advance On-Chain Equity Securities
- Award-winning NJ Author Celebrates New Release and Multi-Author Collaboration
Attendees were also treated to five plenary talks led by pioneers in life sciences. In the opening plenary, Dr. Patrick Bossuyt received the prestigious Wallace H. Coulter Lectureship award and spoke about his experiences leading efforts to improve diagnostic tests. He made a compelling case for why strong clinical trials of laboratory tests are necessary.
On Monday, Dr. Kojo S.J. Elenitoba-Johnson from Memorial Sloan Kettering Cancer Center discussed how proteomic data can help healthcare professionals better understand lymphomas and develop precision oncology therapies.
Tuesday's plenary speaker was Dr. Ron H.N. van Schaik from Erasmus MC - University Medical Center Rotterdam who talked about implementing pharmacogenetics as a diagnostic tool in routine healthcare. He shared both the successes and challenges of this approach.
On Wednesday, Dr. Sharon Hillier from the University of Pittsburgh explored the development of new products for HIV prevention, including those that can be used on demand and minimize exposure to antiretroviral drugs.
The closing keynote speaker, Dr. Diana Greene Foster from the University of California, San Francisco, discussed the mental health, physical health, and socioeconomic consequences faced by individuals who are unable to get an abortion.
More on eTravel Wire
- Therapy 911 Launches Mental Health Social Network to Celebrate Mental Health Awareness Month
- Bosco's Beach Launches Vacation Rentals in Panama City Beach, Florida
- $7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- One Park Financial Once Again Honored with Sun Sentinel's Top Workplaces Award for the 8th Time — Achieves Best Ranking Yet in 2025
- Orlando Area's Top Luxury and Adventure Brands Partner for Memorial Day Giveaway
As part of ADLM's Disruptive Technology Award competition, biotech innovators presented novel technologies that could improve accurate diagnoses for more patients. The winner was Mercy BioAnalytics with their liquid biopsy platform that detects ovarian cancer in its earliest stages by measuring tumor-derived extracellular vesicles.
The ADLM 2024 Clinical Lab Expo featured nearly 900 exhibitors and covered an impressive 271,003 net square feet. This marks a 5% increase in exhibit space since the last time the meeting was held in Chicago. The expo showcased cutting-edge tests from all laboratory medicine disciplines, including artificial intelligence, molecular diagnostics, automation, point-of-care testing, mass spectrometry, mobile health, and more.
ADLM CEO Mark J. Golden expressed his excitement about the increased attendance at ADLM 2024 after the challenges faced during the COVID-19 pandemic. He also acknowledged that this has been a challenging year for laboratory medicine professionals with the FDA's final rule on laboratory developed tests. The meeting provided a crucial opportunity for attendees to learn more about what this rule means for their labs and patient care. Golden hopes that attendees will return home inspired and eager to implement what they've learned at this year's meeting in their work. He also looks forward to seeing what next year's meeting in Chicago from July 27-31 will bring.
In conclusion, ADLM 2024 was a resounding success with record-breaking attendance and groundbreaking advancements in diagnostic research and technology. The meeting provided a vital platform for laboratory medicine professionals to learn, network, and stay updated on the latest developments in their field.
0 Comments
Latest on eTravel Wire
- $34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
- Pikmykid Launches $100,000 School Safety Grant Giveaway to Support K–12 Schools Across the U.S
- Bavarian Inn Lodge Recognized in 2025 TripAdvisor Travelers' Choice Awards
- Slotozilla Data Report: Unveiling 2024's Gaming Statistics
- BK Flooring Releases Their Top Reasons to Upgrade Kitchen Tile Flooring in 2025
- The OpenSSL Corporation and the OpenSSL Foundation Certify Results of Technical Advisory Committee Elections
- ROME-ANTICS Unleashed: A Music Video by Sidow Sobrino Transforms Rome into a Living Stage
- Mother's Day Wake-Up Call for Maternal Health: New Initiative Demands Better Postpartum Support
- Southbox Entertainment, FinTech Pioneer & Entrepreneur Jon Gosier Join Psychological Thriller The Dutchman as Financing Partner
- SlotCycle Joins Association of Gaming Equipment Manufacturers (AGEM) to Advance Sustainable Gaming Solutions
- Florida's Summer Bioluminescence Begins—See the Glow Before It Sells Out!
- RWA Infra Development L.L.C. announces the $RWAID token. "$RWAID tokenizing infrastructure for the masses."
- Adventure is in the Journey with the New Lumber Heritage Trail Interactive Mobile App
- Mental Health Awareness Month—Tennessee Enacts Psychotropic Testing Law
- Be Prepared for the Qualitative and Quantitative Effects of Tariffs: How Businesses Can Navigate Potential Disruption in Finances and Production
- Bold Beauty Project UCLA Edition Photography Exhibition on May 18
- Genuine Hospitality, LLC Selected to Operate Claridge House Chicago Gold Coast
- Lamar Odom Issues Public Challenge to X Platform Over Censorship of His Anti-Addiction Crypto Campaign
- PBK Miner completes $80 million Series B financing to support AI cloud mining and increase user investment return by 25%
- Asset-Backed Green Crypto: Fueling the Trillion-Dollar Revolution